Drug intelligence / Profile preview

Fentora

Development stage
Unknown
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Buccal
01

Overview

Fentora is an opioid analgesic formulation of fentanyl citrate designed for buccal administration using the proprietary OraVescent delivery system. Developed by Cephalon (now a subsidiary of Teva), it is specifically indicated for the management of breakthrough pain in opioid-tolerant patients with cancer. The OraVescent technology utilizes an effervescent reaction to adjust the local pH, which enhances the rate and extent of fentanyl absorption through the buccal mucosa compared to standard oral formulations. While primarily used in oncology, it has been evaluated in Phase 3 trials for breakthrough pain in chronic non-cancer pain conditions, such as back pain and osteoarthritis, although its use in these populations remains restricted due to safety and abuse concerns.

Brand names
Fentora
Other names
fentanyl buccal tabletOraVescent fentanylfentanyl citrate
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Fentora.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fentora.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call